Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinji Takeuchi

Showing results (61-70 of 116) with videos related to

Pageof 12
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 22, 2012
[A case of poorly-differentiated neuroendocrine carcinoma of the ascending colon with multiple liver metastases successfully treated with cisplatin and irinotecan]Kaname Yamashita, Daisuke Ishikawa, Shigeki Nanjo, et al.
Medicine International|June 28, 2024
Clinical outcome of patients with inoperable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus Nab‑paclitaxel as a first‑line therapy: A retrospective analysisHiroyuki Sakaguchi, Azusa Tanimoto, Shigeki Sato, et al.
Cell Reports. Medicine|May 22, 2024
Targeting WEE1 enhances the antitumor effect of KRAS-mutated non-small cell lung cancer harboring TP53 mutationsKoji Fukuda, Shinji Takeuchi, Sachiko Arai, et al.
Cancer Science|January 13, 2015
In vivo imaging models of bone and brain metastases and pleural carcinomatosis with a novel human EML4-ALK lung cancer cell lineShigeki Nanjo, Takayuki Nakagawa, Shinji Takeuchi, et al.
Ground Water|April 21, 2016
An Application of Hydraulic Tomography to a Large-Scale Fractured Granite Site, Mizunami, JapanYuanyuan Zha, Tian-Chyi J Yeh, Walter A Illman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2012
Paracrine receptor activation by microenvironment triggers bypass survival signals and ALK inhibitor resistance in EML4-ALK lung cancer cellsTadaaki Yamada, Shinji Takeuchi, Junya Nakade, et al.
Cancer Diagnosis & Prognosis|May 9, 2022
Methylation of Tumor Suppressive miRNAs in Plasma from Patients With Pancreaticobiliary DiseasesKoushiro Ohtsubo, Kunio Miyake, Sachiko Arai, et al.
Plos One|January 4, 2014
Ability of the Met kinase inhibitor crizotinib and new generation EGFR inhibitors to overcome resistance to EGFR inhibitorsShigeki Nanjo, Tadaaki Yamada, Hiroshi Nishihara, et al.
Cancer Research|August 22, 2015
Akt Kinase-Interacting Protein 1 Signals through CREB to Drive Diffuse Malignant MesotheliomaTadaaki Yamada, Joseph M Amann, Koji Fukuda, et al.
Molecular and Clinical Oncology|April 14, 2016
Recurrence of renal cell carcinoma diagnosed using contralateral adrenal biopsy with endoscopic ultrasound-guided fine-needle aspirationAzusa Tanimoto, Shinji Takeuchi, Hiroshi Yaegashi, et al.
Pageof 12

Showing results (61-70 of 116) with videos related to

Sort By:
Pageof 12
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 22, 2012
[A case of poorly-differentiated neuroendocrine carcinoma of the ascending colon with multiple liver metastases successfully treated with cisplatin and irinotecan]Kaname Yamashita, Daisuke Ishikawa, Shigeki Nanjo, et al.
Medicine International|June 28, 2024
Clinical outcome of patients with inoperable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus Nab‑paclitaxel as a first‑line therapy: A retrospective analysisHiroyuki Sakaguchi, Azusa Tanimoto, Shigeki Sato, et al.
Cell Reports. Medicine|May 22, 2024
Targeting WEE1 enhances the antitumor effect of KRAS-mutated non-small cell lung cancer harboring TP53 mutationsKoji Fukuda, Shinji Takeuchi, Sachiko Arai, et al.
Cancer Science|January 13, 2015
In vivo imaging models of bone and brain metastases and pleural carcinomatosis with a novel human EML4-ALK lung cancer cell lineShigeki Nanjo, Takayuki Nakagawa, Shinji Takeuchi, et al.
Ground Water|April 21, 2016
An Application of Hydraulic Tomography to a Large-Scale Fractured Granite Site, Mizunami, JapanYuanyuan Zha, Tian-Chyi J Yeh, Walter A Illman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2012
Paracrine receptor activation by microenvironment triggers bypass survival signals and ALK inhibitor resistance in EML4-ALK lung cancer cellsTadaaki Yamada, Shinji Takeuchi, Junya Nakade, et al.
Cancer Diagnosis & Prognosis|May 9, 2022
Methylation of Tumor Suppressive miRNAs in Plasma from Patients With Pancreaticobiliary DiseasesKoushiro Ohtsubo, Kunio Miyake, Sachiko Arai, et al.
Plos One|January 4, 2014
Ability of the Met kinase inhibitor crizotinib and new generation EGFR inhibitors to overcome resistance to EGFR inhibitorsShigeki Nanjo, Tadaaki Yamada, Hiroshi Nishihara, et al.
Cancer Research|August 22, 2015
Akt Kinase-Interacting Protein 1 Signals through CREB to Drive Diffuse Malignant MesotheliomaTadaaki Yamada, Joseph M Amann, Koji Fukuda, et al.
Molecular and Clinical Oncology|April 14, 2016
Recurrence of renal cell carcinoma diagnosed using contralateral adrenal biopsy with endoscopic ultrasound-guided fine-needle aspirationAzusa Tanimoto, Shinji Takeuchi, Hiroshi Yaegashi, et al.
Pageof 12